chartexchange

IFRX
InflaRx N.V. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
1.10USD-4.348%(-0.05)3,047,841
After-hoursNov 18, 2026 4:00:30 PM EST
1.11USD+0.909%(+0.01)
Loading…
Loading…
162.11M
Healthcare
Biotechnology
HQ
Jena, Thueringen, Germany
Previous Close
$1.15
Beta
1.58
52-Week High
$2.95 2026-05-07
52-Week Low
$0.80 2026-02-05
SMA 50
$1.63
SMA 200
$1.66
Avg. Vol 10D
1.12M
Avg. Vol 30D
1.10M
Avg. Vol 90D
873,479
Relative Vol
2.78
147.37M
125.63M
12,844,927
2.2100%
9,915
IFRX Profile

inflarx n.v., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using c5a technology primarily in the germany and united states. its c5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. the company's lead product candidate is ifx-1, an intravenously delivered first-in-class anti-c5a monoclonal antibody, which completed the phase iib clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat anca-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of pyoderma gangrenosum, a chronic inflammatory skin disorder, as well as developing ifx-1 for the treatment of oncological diseases. it also develops ifx-2 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. inflarx n.v. has co-development agreement with beijing defe

IFRX Performance
PeriodPriceDateChangeBeta
1W1.242026-11-12-11.29%-3.372
1M1.452026-10-19-24.14%0.694
3M2.122026-08-19-48.11%1.248
6M2.372026-05-19-53.59%1.276
1Y1.262025-11-19-12.70%1.581
2Y1.922024-11-19-42.71%—
5Y4.762021-11-19-76.89%0.826
IFRX Stock Summary

InflaRx N.V. Common Stock (NASDAQ:IFRX) stock price today is $1.10, and today's volume is 3,047,841. IFRX is down 4.348% today. The 30 day average volume is 1.10M. IFRX market cap is $162.11M with 147.37M shares outstanding.